The E3 Ubiquitin Ligase RLIM Safeguards Oligodendrocyte Development and Myelination by Targeting SLC7A11 for Polyubiquitination to Regulate Ferroptotic Resistance
Advanced Science · 2026
DOI: 10.1002/advs.76315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuwei Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Evolution and Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Amino Acid Transport System y+, Oligodendroglia, Ubiquitin-Protein Ligases, Myelin Sheath. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Science and Technology Department of Yunnan Province.
Abstract (Originalsprache)
In the central nervous system, oligodendrocytes (OLs) generate myelin sheaths to support rapid nerve impulse conduction. OL lineage cells, especially oligodendrocyte precursor cells (OPCs), feature high metabolic activity and are exposed to severe oxidative stress, but the protective mechanisms remain poorly understood. Here we show that RLIM, an E3 ubiquitin ligase linked to X‐linked neurodevelopmental disorders, safeguards OL development via ferroptosis resistance. RLIM directly polyubiquitinates SLC7A11, a key cystine/glutamate antiporter for glutathione (GSH) synthesis, thereby sustaining SLC7A11 membrane localization. OL lineage‐specific ablation of RLIM in mice reduces membrane SLC7A11, impairs OPC proliferation, and triggers ferroptosis and thus myelination defects, leading to motor, social, and cognitive deficits that mimic patient phenotypes. Most pathological RLIM missense variants disrupt SLC7A11 binding and/or polyubiquitination. Importantly, GSH supplementation rescues myelination defects and behavioral abnormalities in RLIM‐deficient mice. These findings reveal that the RLIM–SLC7A11‐GSH signaling axis governs ferroptosis resistance in OL lineage cells, implicates this pathway in RLIM‐related neurodevelopmental disorders, and suggests GSH as a potential therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Genetic Evolution and Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
- Department of Reproduction and Genetics, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
- Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, China.
- National Research Facility for Phenotypic & Genetic Analysis of Model Animals (Primate Facility), Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China.
ORCID-Profile: Yuwei Li, Bingyu Mao, Pengcheng Ma
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Science and Technology Department of Yunnan Province
- CAS "Light of West China" Program
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- Yunnan Revitalization Talent Support Program Yunling Scholar Project
Zitieren
APA
Li, Y., Zhang, H., Zhou, J., Yang, S., Cha, J., Yan, G., Zhao, S., Mao, B., & Ma, P. (2026). The E3 Ubiquitin Ligase RLIM Safeguards Oligodendrocyte Development and Myelination by Targeting SLC7A11 for Polyubiquitination to Regulate Ferroptotic Resistance. Advanced Science. https://doi.org/10.1002/advs.76315
Vancouver
Li Y, Zhang H, Zhou J, Yang S, Cha J, Yan G, et al. The E3 Ubiquitin Ligase RLIM Safeguards Oligodendrocyte Development and Myelination by Targeting SLC7A11 for Polyubiquitination to Regulate Ferroptotic Resistance. Advanced Science. 2026. doi:10.1002/advs.76315
BibTeX
@article{Li2026,
author = {Li, Yuwei and Zhang, Haijun and Zhou, Jieya and Yang, Shiyu and Cha, Jingmei and Yan, Gaofeng and Zhao, Shuhua and Mao, Bingyu and Ma, Pengcheng},
title = {The E3 Ubiquitin Ligase RLIM Safeguards Oligodendrocyte Development and Myelination by Targeting SLC7A11 for Polyubiquitination to Regulate Ferroptotic Resistance},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76315}
}
EUVIMED